These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
190 related articles for article (PubMed ID: 24519316)
1. Prediction of glucuronidated drug clearance in pediatrics (≤5 years): An allometric approach. Mahmood I Eur J Drug Metab Pharmacokinet; 2015 Mar; 40(1):53-9. PubMed ID: 24519316 [TBL] [Abstract][Full Text] [Related]
2. Prediction of Clearance in Neonates and Infants (≤ 3 Months of Age) for Drugs That Are Glucuronidated: A Comparative Study Between Allometric Scaling and Physiologically Based Pharmacokinetic Modeling. Mahmood I; Ahmad T; Mansoor N; Sharib SM J Clin Pharmacol; 2017 Apr; 57(4):476-483. PubMed ID: 27704554 [TBL] [Abstract][Full Text] [Related]
3. Prediction of Drug Clearance in Premature and Mature Neonates, Infants, and Children ≤2 Years of Age: A Comparison of the Predictive Performance of 4 Allometric Models. Mahmood I J Clin Pharmacol; 2016 Jun; 56(6):733-9. PubMed ID: 26437918 [TBL] [Abstract][Full Text] [Related]
4. Prediction of Clearance, Volume of distribution, and Half-life of Drugs in Extremely Low to Low Birth Weight Neonates: An Allometric Approach. Mahmood I Eur J Drug Metab Pharmacokinet; 2017 Aug; 42(4):601-610. PubMed ID: 27562171 [TBL] [Abstract][Full Text] [Related]
5. Prediction of drug clearance in children: an evaluation of the predictive performance of several models. Mahmood I; Staschen CM; Goteti K AAPS J; 2014 Nov; 16(6):1334-43. PubMed ID: 25274608 [TBL] [Abstract][Full Text] [Related]
6. Prediction of drug clearance in children: impact of allometric exponents, body weight, and age. Mahmood I Ther Drug Monit; 2007 Jun; 29(3):271-8. PubMed ID: 17529882 [TBL] [Abstract][Full Text] [Related]
7. Population Pharmacokinetics: Some Observations in Pediatric Modeling for Drug Clearance. Mahmood I; Tegenge MA Clin Pharmacokinet; 2017 Dec; 56(12):1567-1576. PubMed ID: 28405936 [TBL] [Abstract][Full Text] [Related]
8. The integration of allometry and virtual populations to predict clearance and clearance variability in pediatric populations over the age of 6 years. Edginton AN; Shah B; Sevestre M; Momper JD Clin Pharmacokinet; 2013 Aug; 52(8):693-703. PubMed ID: 23588537 [TBL] [Abstract][Full Text] [Related]
9. Prediction of propofol clearance in children from an allometric model developed in rats, children and adults versus a 0.75 fixed-exponent allometric model. Peeters MY; Allegaert K; Blussé van Oud-Alblas HJ; Cella M; Tibboel D; Danhof M; Knibbe CA Clin Pharmacokinet; 2010 Apr; 49(4):269-75. PubMed ID: 20214410 [TBL] [Abstract][Full Text] [Related]
10. Allometry Is a Reasonable Choice in Pediatric Drug Development. Liu T; Ghafoori P; Gobburu JV J Clin Pharmacol; 2017 Apr; 57(4):469-475. PubMed ID: 27649629 [TBL] [Abstract][Full Text] [Related]
11. Prediction of drug clearance in children. Foissac F; Bouazza N; Valade E; De Sousa Mendes M; Fauchet F; Benaboud S; Hirt D; Tréluyer JM; Urien S J Clin Pharmacol; 2015 Jul; 55(7):739-47. PubMed ID: 25721251 [TBL] [Abstract][Full Text] [Related]
12. In vitro analysis of human drug glucuronidation and prediction of in vivo metabolic clearance. Soars MG; Burchell B; Riley RJ J Pharmacol Exp Ther; 2002 Apr; 301(1):382-90. PubMed ID: 11907196 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of sigmoidal maturation and allometric models: prediction of propofol clearance in neonates and infants. Mahmood I Am J Ther; 2013 Jan; 20(1):21-8. PubMed ID: 23299229 [TBL] [Abstract][Full Text] [Related]
14. Prediction of Clearance and Dose of Midazolam in Preterm and Term Neonates: A Comparative Study Between Allometric Scaling and Physiologically Based Pharmacokinetic Modeling. Mansoor N; Ahmad T; Alam Khan R; Sharib SM; Mahmood I Am J Ther; 2019; 26(1):e32-e37. PubMed ID: 27574923 [TBL] [Abstract][Full Text] [Related]
15. Prediction of Antimalarial Drug Clearance in Children: A Comparison of Three Different Interspecies Scaling Methods. Mahmood I; Cheng A; Brauer E; Humeniuk R Eur J Drug Metab Pharmacokinet; 2016 Dec; 41(6):767-775. PubMed ID: 26547922 [TBL] [Abstract][Full Text] [Related]
16. Allometric extrapolation of factors VII, VIII and IX clearance in children from adults. Mahmood I J Thromb Haemost; 2012 Aug; 10(8):1609-13. PubMed ID: 22612736 [TBL] [Abstract][Full Text] [Related]
17. Age- and Bodyweight-dependent Allometric Exponent Model for Scaling Clearance and Maintenance Dose of Theophylline From Neonates to Adults. Tegenge MA; Mahmood I Ther Drug Monit; 2018 Oct; 40(5):635-641. PubMed ID: 30086085 [TBL] [Abstract][Full Text] [Related]
18. Predicting the "First dose in children" of CYP3A-metabolized drugs: Evaluation of scaling approaches and insights into the CYP3A7-CYP3A4 switch at young ages. Strougo A; Yassen A; Monnereau C; Danhof M; Freijer J J Clin Pharmacol; 2014 Sep; 54(9):1006-15. PubMed ID: 24676942 [TBL] [Abstract][Full Text] [Related]
19. A Comparative Study Between Allometric Scaling and Physiologically Based Pharmacokinetic Modeling for the Prediction of Drug Clearance From Neonates to Adolescents. Mahmood I; Tegenge MA J Clin Pharmacol; 2019 Feb; 59(2):189-197. PubMed ID: 30192373 [TBL] [Abstract][Full Text] [Related]
20. Evaluation of a morphine maturation model for the prediction of morphine clearance in children: how accurate is the predictive performance of the model? Mahmood I Br J Clin Pharmacol; 2011 Jan; 71(1):88-94. PubMed ID: 21143504 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]